Arpelos Biosciences
PrivateLast Round
Seed
Mar 15, 2024
Total Funding Raised
$9.6M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Arpelos Biosciences operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in March 2024.
Arpelos Biosciences is a biotechnology company that develops multivalent medicines to achieve unprecedented potency and selectivity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arpelos Biosciences Comparables
Compare Arpelos Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synthetic Design Lab | 84% | |
| Valink Therapeutics | 82% | |
| AI Proteins | 76% |
For institutional investors. Book with your work email.
Arpelos Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Arpelos Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lux Capital | Seed |
| General Catalyst | Seed |
| Pillar VC | Seed |
| Wing Venture Capital | Seed |
| 82VS | Seed |
| 8VC | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 32% MoM.
- Jun 18, 2026
Monthly visitors grew 42% MoM.
For institutional investors. Book with your work email.
Arpelos Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Arpelos Biosciences's valuation, stock price, and market status.
Is Arpelos Biosciences a public or private company?
Arpelos Biosciences is a private company.
What is the current stock price of Arpelos Biosciences?
Arpelos Biosciences is a private company, so its shares have no public market price. Caplight tracks Arpelos Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Arpelos Biosciences worth (valuation)?
Valuation information for Arpelos Biosciences is not publicly available.
Can I buy Arpelos Biosciences stock?
Arpelos Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Arpelos Biosciences's last funding round?
Arpelos Biosciences's most recent funding round was Seed on March 15, 2024.
Who are the main investors in Arpelos Biosciences?
Key investors in Arpelos Biosciences include Lux Capital, General Catalyst, Pillar VC, Wing Venture Capital, 82VS.
Will Arpelos Biosciences IPO soon?
No public IPO plans have been announced for Arpelos Biosciences.
How can I track Arpelos Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Arpelos Biosciences's shares on secondary markets.